Keyphrases
Randomized Clinical Trial
100%
Clinical Benefit
100%
Bempedoic Acid
100%
Hazard Ratio
42%
Confidence Interval
42%
Major Adverse Cardiovascular Events
42%
Clinical Trials
28%
Myocardial Infarction
28%
All-cause Mortality
28%
Meta-analysis
28%
Low-density Lipoprotein Cholesterol (LDL-C)
28%
Myocardial Revascularization
28%
Metanalysis
28%
Intention-to-treat
14%
Cardiovascular Mortality
14%
Significant Risk Factors
14%
High Risk
14%
Systematic Meta-analysis
14%
Risk Reduction
14%
Statins
14%
Reporting Item
14%
Selective Inhibitor
14%
Cardiovascular Outcomes
14%
Risk for Cardiovascular Diseases
14%
Cochrane Collaboration
14%
Low-density Lipoprotein Cholesterol Level
14%
Intolerant
14%
Crude Incidence
14%
Stroke Incidence
14%
Net Clinical Benefit
14%
Acid Groups
14%
Cholesterol Reduction
14%
Certainty of Evidence
14%
Adenosine Triphosphate-citrate Lyase
14%
Medicine and Dentistry
Randomized Clinical Trial
100%
Bempedoic Acid
100%
Cardiovascular System
57%
Hazard Ratio
42%
Cardiovascular Disease
42%
Low Density Lipoprotein Cholesterol
42%
Clinical Trial
28%
Apoplexy
28%
Myocardial Infarction
28%
Meta-Analysis
28%
Heart Muscle Revascularization
28%
Intention-to-Treat Analysis
14%
All Cause Mortality
14%
Systematic Review
14%
Cause of Death
14%
Statin
14%
Risk Reduction
14%
Adenosine Triphosphate Citrate Synthase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Bempedoic Acid
100%
Low Density Lipoprotein Cholesterol
42%
Cardiovascular Disease
42%
Heart Infarction
28%
Clinical Trial
28%
Cerebrovascular Accident
28%
All Cause Mortality
14%
Statin (Protein)
14%
Cause of Death
14%
Adenosine Triphosphate Citrate Synthase
14%